Oncolytics Biotech Inc.

The momentum for this stock is not very good. Oncolytics Biotech Inc. is not very popular among insiders. Oncolytics Biotech Inc. is a mediocre stock to choose.
Log in to see more information.
Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of s...
ONCY Fundamental Data by TradingView

News

Oncolytics Biotech to Participate in Fireside Chats at Two Investment Conferences in September
Oncolytics Biotech to Participate in Fireside Chats at Two Investment Conferences in September

CNW Group - News Releases Oncolytics Biotech to Participate in Fireside Chats at Two Investment Conferences in September Oncolytics Biotech to Participate in Fireside Chats at Two Investment Conferences in September Canada...\n more…

FY2024 EPS Estimates for Oncolytics Biotech Inc. Lowered by HC Wainwright (NASDAQ:ONCY)
FY2024 EPS Estimates for Oncolytics Biotech Inc. Lowered by HC Wainwright (NASDAQ:ONCY)

Zolmax Oncolytics Biotech Inc. (NASDAQ:ONCY - Free Report) - Investment analysts at HC Wainwright lowered their FY2024 EPS estimates for shares of Oncolytics Biotech in a research note issued on...\n more…

Oncolytics Biotech Inc. to Post FY2024 Earnings of ($0.29) Per Share, HC Wainwright Forecasts (NASDAQ:ONCY)
Oncolytics Biotech Inc. to Post FY2024 Earnings of ($0.29) Per Share, HC Wainwright Forecasts (NASDAQ:ONCY)

Ticker Report Oncolytics Biotech Inc. (NASDAQ:ONCY - Free Report) - Investment analysts at HC Wainwright cut their FY2024 earnings per share (EPS) estimates for shares of Oncolytics Biotech in a research note...\n more…

Oncolytics Biotech (NASDAQ:ONCY) Given "Buy" Rating at HC Wainwright
Oncolytics Biotech (NASDAQ:ONCY) Given "Buy" Rating at HC Wainwright

Ticker Report HC Wainwright reaffirmed their buy rating on shares of Oncolytics Biotech (NASDAQ:ONCY - Free Report) in a report published on Wednesday morning, Benzinga reports. They currently have a $5.00 price...\n more…

Sernova Corp. Announces Appointment of New Chief Executive Officer
Sernova Corp. Announces Appointment of New Chief Executive Officer

Globe Newswire LONDON, Ontario and BOSTON, Aug. 12, 2024 (GLOBE NEWSWIRE) -- August 12, 2024. Sernova Corp. ( Sernova or the Company ) (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology...\n more…

51,889 Shares in Oncolytics Biotech Inc. (NASDAQ:ONCY) Bought by Virtu Financial LLC
51,889 Shares in Oncolytics Biotech Inc. (NASDAQ:ONCY) Bought by Virtu Financial LLC

Ticker Report Virtu Financial LLC acquired a new stake in Oncolytics Biotech Inc. (NASDAQ:ONCY - Free Report) in the first quarter, HoldingsChannel reports. The institutional investor acquired 51,889 shares of the...\n more…